Kevin Rubin Joins Zscaler as Chief Financial Officer to Drive Continued Growth

(NASDAQ:ZS), SAN JOSE, Calif., May 29, 2025 (GLOBE NEWSWIRE) — Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced the appointment of Kevin Rubin as Chief Financial Officer. In his role, Rubin will oversee Zscaler's global finance organization and play a critical role in scaling the company's operations to support its next phase […]

CODI DEADLINE NOTICE: Compass Diversified Holdings Investors are Alerted to Contact BFA Law prior to the July 8 Securities Fraud Class Action Deadline

NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Compass Diversified Holdings and Compass Group Diversified Holdings, LLC (NYSE:CODI) and certain of the Company’s senior executives for potential violations of the federal securities laws. If

Kevin Rubin Joins Zscaler as Chief Financial Officer to Drive Continued Growth

Kevin Rubin Joins Zscaler as Chief Financial Officer to Drive Continued Growth GlobeNewswire May 29, 2025 SAN JOSE, Calif., May 29, 2025 (GLOBE NEWSWIRE) — Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced the appointment of Kevin Rubin as Chief Financial Officer. In his role, Rubin will oversee Zscaler's global finance organization

Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17

STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, is rescheduling its intra-quarter webcast and investor update call to June 17, 2025, from June 3, 2025, to allow for the implementation of a reverse stock

Avadel Pharmaceuticals to Present New Data on LUMRYZ(TM) (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025

(NasdaqGM:AVDL), – 14 abstracts accepted, including four oral presentations – – Interim analysis of real-world REFRESH study demonstrated clinically significant efficacy and improvement of EDS for patients who switched from twice-nightly oxybate to once-at-bedtime LUMRYZ – – Data reflecting the therapeutic results of LUMRYZ treatment in people with narcolepsy across clinical as well as real-world

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

(NasdaqGM:GPCR), SAN FRANCISCO, May 29, 2025 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced that management will participate in multiple upcoming healthcare conferences in June. Jefferies Global Healthcare Conference Format: Fireside chat and 1×1 meetingsDate/time: Thursday, June 5 at

MondelĂ„”z International Expands Sustainable Futures Portfolio Aiming to Accelerate Scalable Climate and Community Initiatives

(NASDAQ:MDLZ), New investments span regenerative agriculture, inclusive financing, and circular packaging ambitions through innovative technology. Investments reflect the company's three-pronged approach across direct investments, fund investments, and technical assistance to help support bold initiatives. Sustainable Futures focus on circularity, community, and climate aligns with company's Vision 2030 Sustainability strategy and aims to help people and

Sunrise Realty Trust Expands Revolving Credit Facility to $140 Million with Addition of EverBank as Joint Lead Arranger

(NASDAQ:SUNS), WEST PALM BEACH, Fla., May 29, 2025 (GLOBE NEWSWIRE) — Sunrise Realty Trust, Inc. (“SUNS” or the “Company”) (Nasdaq: SUNS), a lender on the TCG Real Estate platform, today announced the expansion of its senior secured revolving credit facility (the “Credit Facility”) with the addition of EverBank, N.A. (“EverBank”). EverBank has committed $50 million

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June

(NasdaqGM:RLAY), CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will participate in two upcoming fireside chats in June: Jefferies Global Healthcare Conference on Wednesday, June 4, 2025 at 8:45

FLUENT Reports First Quarter 2025 Results

(Other OTC:CNTMF),(OTC US:CNTMF),(CNSX:FNT-U.CN),(CNSX:FNT.U), – Q1 Revenue Grew 5.91% YoY to $26.7 million– Ended quarter with $30.7 million of cash and cash equivalents– New York operations continuing to progress as Buffalo cultivation facility nears completion TAMPA, Fla., May 29, 2025 (GLOBE NEWSWIRE) — FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a vertically-integrated, multi-state

Scroll to Top